| COVID-19 |
1 |
1 |
| Antibiotics |
0 |
0.55 |
| Microbicides |
0 |
0.49 |
| Antimicrobial Resistance |
0 |
0.45 |
| Outbreak |
0 |
0.42 |
| NHS |
0 |
0.41 |
| Antimicrobial Stewardship |
0 |
0.4 |
| Fungal Infection |
0 |
0.35 |
| Pandemic |
0 |
0.35 |
| Health Care Facilities, Manpower, and Services |
0 |
0.99 |
| Pneumonia |
0 |
0.22 |
| Bacteria |
0 |
0.21 |
| Clinical Guidelines |
0 |
0.21 |
| Severe Acute Respiratory Syndrome |
0 |
0.21 |
| Acute Respiratory Distress Syndrome |
0 |
0.2 |
| Gram-Negative Bacteria |
0 |
0.2 |
| Gram-Positive Bacteria |
0 |
0.2 |
| Hospital-Acquired Infection |
0 |
0.98 |
| Mechanical Ventilation |
0 |
0.15 |
| Bronchoalveolar Lavage |
0 |
0.14 |
| Genomic Medicine |
0 |
0.14 |
| Infection Control |
0 |
0.97 |
| Liquid Biopsy |
0 |
0.13 |
| Antibiotic Resistance |
0 |
0.07 |
| Biopsy |
0 |
0.07 |
| Candida |
0 |
0.07 |
| Fluid, Electrolyte, and Nutrition Management of the Newborn |
0 |
0.07 |
| Fungal Pneumonia |
0 |
0.07 |
| Generics |
0 |
0.07 |
| Genetics |
0 |
0.07 |
| Health Care Reform |
0 |
0.07 |
| Hospital |
0 |
0.07 |
| Influenza |
0 |
0.07 |
| Intensive Care Unit |
0 |
0.96 |
| Klebsiella Infections |
0 |
0.07 |
| Lung |
0 |
0.07 |
| Nutritional Support |
0 |
0.07 |
| Outpatient Clinic |
0 |
0.07 |
| Polymerase Chain Reaction |
0 |
0.07 |
| Staphylococcal Infection |
0 |
0.07 |
| Staphylococcus Aureus Infection |
0 |
0.07 |
| Steroids |
0 |
0.07 |
| Tissue |
0 |
0.07 |
| Trachea |
0 |
0.07 |
| UK Site Content |
0 |
0.07 |
| Ventilator |
0 |
0.07 |